Overview of Radioactive Iodine-Resistant Differentiated Thyroid Cancer

被引：0
|
作者：
Sherman, Steven I.
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2014年 / 12卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3 / 5
页数：3
相关论文
共 50 条
  • [1] Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer
    Boucher, Andree
    Ezzat, Shereen
    Hotte, Sebastien
    Rachinsky, Irina
    Rajaraman, Murali
    Ruether, Dean
    Wiseman, Sam M.
    Brierley, James
    Ho, Cheryl
    Krzyzanowska, Monika
    Lamond, Nathan
    Massicotte, Marie-Helene
    Joseph, Shereen
    Herscovitch, Kassey
    Sikora, Lindsey
    Winquist, Eric
    [J]. ORAL ONCOLOGY, 2021, 121
  • [2] Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
    Fullmer, Tanner
    Cabanillas, Maria E. E.
    Zafereo, Mark
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [3] Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy
    Schechter, Rebecca B.
    Nagilla, Madhavi
    Joseph, Loren
    Reddy, Poluru
    Khattri, Arun
    Watson, Sydeaka
    Locati, Laura D.
    Licitra, Lisa
    Greco, Angela
    Pelosi, Giuseppe
    Carcangiu, Maria Luisa
    Lingen, Mark W.
    Seiwert, Tanguy Y.
    Cohen, Ezra E. W.
    [J]. CANCER LETTERS, 2015, 359 (02) : 269 - 274
  • [4] OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS
    Jasim, Sina
    Iniguez-Ariza, Nicole M.
    Hilger, Crystal R.
    Chintakuntlawar, Ashish V.
    Ryder, Mabel M.
    Morris, John C., III
    Bible, Keith C.
    [J]. ENDOCRINE PRACTICE, 2017, 23 (10) : 1254 - 1261
  • [5] Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer
    Ibrahim, Eiman Y.
    Busaidy, Naifa L.
    [J]. CURRENT OPINION IN ONCOLOGY, 2017, 29 (02) : 151 - 158
  • [6] Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer
    Balakirouchenane, David
    Seban, Romain
    Groussin, Lionel
    Puszkiel, Alicja
    Cottereau, Anne Segolene
    Clerc, Jerome
    Vidal, Michel
    Goldwasser, Francois
    Arrondeau, Jennifer
    Blanchet, Benoit
    Huillard, Olivier
    [J]. THYROID, 2023, 33 (11) : 1327 - 1338
  • [7] Radioactive Iodine in Differentiated Carcinoma of Thyroid: An Overview
    Singh, Namit Kant
    Ramamourthy, Balaji
    Hage, Neemu
    Nagaraju, Sushmitha
    Kappagantu, Krishna Medha
    [J]. CURRENT RADIOPHARMACEUTICALS, 2024, 17 (01) : 2 - 6
  • [8] Molecular predictors of response to sorafenib in patients with radioactive iodine-resistant advanced thyroid cancer.
    Yarchoan, Mark
    Cohen, Aaron Benjamin
    Stopenski, Stephen J.
    Haddad, Chia A.
    Scott, Nathan L.
    Ma, Cathy
    Ransom, Evan R.
    Troxel, Andrea B.
    Feldman, Michael D.
    Brose, Marcia S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Radioactive iodine therapy in poorly differentiated thyroid cancer
    R Michael Tuttle
    Ravinder K Grewal
    Steve M Larson
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 665 - 668
  • [10] Radioactive iodine therapy in poorly differentiated thyroid cancer
    Tuttle, R. Michael
    Grewal, Ravinder K.
    Larson, Steve M.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 665 - 668
12345